Effect of pinealectomy and melatonin replacement on morphological and biochemical recovery after traumatic brain injury

International Journal of Developmental Neuroscience

Volumn 24, Issue 6, 2006, Pages 357-363

  Ates, Ozkan ^a   Cayli, Suleyman ^a   Gurses, Iclal ^a   Yucel, Neslihan ^a   Iraz, Mustafa ^a   Altinoz, Eyup ^a   Kocak, Ayhan ^a   Yologlu, Saim ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Melatonin; Oxidative stress; Pinealectomy; Traumatic brain injury

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; MELATONIN; NITRIC OXIDE; SCAVENGER; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CRANIOTOMY; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PINEALECTOMY; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; FREE RADICAL SCAVENGERS; GLUTATHIONE; MALE; MALONDIALDEHYDE; MELATONIN; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PINEAL GLAND; RATS; RATS, WISTAR;

ANIMALIA;

EID: 33748310905     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2006.08.003     Document Type: Article

References (51)

1. Anderson D.K., and Means E.D. Iron-induced lipid peroxidation in spinal cord: protection with mannitol and methylprednisolone. J. Free Rad. Biol. Med. 1 (1985) 59-64
2. Antolin I., Rodriguez C., Sainz R.M., Mayo J.C., Uria H., Kotler M.L., Colunga M.J.R., Tolivia D., and Menendez-Pelaez A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10 (1996) 882-890
3. Awasthi D., Church D.F., Torbati D., Carrey M.E., and Pryor W.A. Oxidative stress following traumatic brain injury in rats. Surg. Neurol. 47 (1997) 575-582
4. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M., Menendez-Pelaez A., Chen L.D., and Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26 (1995) 497-502
5. Beni S.M., Kohen R., Reiter R.J., Tan D.X., and Shohami E. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-κB and AP-1. FASEB J. 18 (2004) 149-151
6. Bettahi I., Pozo D., Osuna C., Reiter R.J., Acuna-Castroviejo D., and Guerrero J.M. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J. Pineal Res. 20 (1996) 205-210
7. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., and Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diab. Metab. 26 (2000) 163-176
8. Cirak B., Rousan N., Kocak A., Palaoglu S., and Kilic K. Melatonin as a free radical scavenger in experimental head trauma. Pediatr. Neurosurg. 31 (1999) 298-301
9. Corte E.D., and Stirpe F. The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem. J. 126 (1972) 739-745
10. De Butto M., Fortin T., and Pappas B.A. Pinealectomy: behavioral and neuropathological consequences in a chronic cerebral hypoperfusion model. Neurobiol. Aging 23 (2002) 309-317
11. Demediuk P., Saunders R.D., Clendenon N.R., Means E.D., Anderson D.K., and Horrocks L.A. Changes in lipid metabolism in traumatized spinal cord. Prog. Brain Res. 63 (1985) 211-216
12. Dundar K., Topal T., Ay H., Oter S., and Korkmaz A. Protective effects of exogenously administered or endogenously produced melatonin on hyperbaric oxygen-induced oxidative stres in rat brain. Clin. Exp. Pharmacol. Physiol. 32 (2005) 926-930
13. Elangovan V., Kohen R., and Shohami E. Neurological recovery from closed head injury is impaired in diabetic rats. J. Neurotrauma 17 (2000) 1013-1027
14. Ellman G.L. Tissue sulphydryl groups. Arch. Biochem. Biophys. 82 (1959) 70-77
15. Ercan M., Inci S., Kilinc K., Palaoglu S., and Aypar U. Nimodipine attenuates lipid peroxidation during the acute phase of head trauma in rats. Neurosurg. Rev. 24 (2001) 127-130
16. Feeney D.M., Boyeson M.G., Linn R.T., Murray H.M., and Dail W.G. Responses to cortical injury. I. Methodology and local effects of contusions in the rat. Brain Res. 211 (1981) 67-77
17. Hall E.D. Lipid antioxidants in acute central nervous system injury. Ann. Emerg. Med. 22 (1993) 1022-1027
18. Hardeland R., Balzer I., Poeggeler B., Fuhrberg B., Uria H., Behrmann G., Wolf R., Meyer T.J., and Reiter R.J. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J. Pineal Res. 18 (1995) 104-111
19. Hoffman R.A., and Reiter R.J. Rapid pinealectomy in hamsters and other small rodents. Anat. Rec. 153 (1965) 19-22
20. Horakova L., Ondrejickova O., Bachrata K., and Vajdova M. Preventive effect of several antioxidants after oxidative stress on rat brain homogenates. Gen. Physiol. Biophys. 19 (2000) 195-205
21. Ikeda Y., and Long D.M. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery 27 (1990) 1-11
22. Itoh T., Kawamaki M., Yamauchi Y., Shimizu S., and Nakamura M. Effect of allopurinol on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats. Stroke 17 (1986) 1284-1287
23. Juurlink B.H., and Paterson P.G. Review of oxidative stress in brain and spinal cord injury: pharmacological and nutritional management strategies. J. Spinal Cord Med. 21 (1998) 309-334
24. Kanemitsu H., Tamura A., Kirino T., Oka K., Sano K., Iwamoto T., Youshiura M., and Iriyama K. Allopurinol inhibits uric acid accumulation in the rat brain following focal cerebral ischemia. Brain Res. 499 (1989) 367-370
25. Kerman M., Cirak B., Ozguner M.F., Dagtekin A., Sutcu R., Altuntas I., and Delibas N. Does melatonin protect or treat brain damage from traumatic oxidative stress?. Exp. Brain Res. 163 (2005) 406-410
26. Marklund N., Salci K., Lewen A., and Hillered L. Glycerol as a marker for post-traumaticmembrane phospholipid degradation in rat brain. Neuroreport 717 (1997) 109-117
27. McCord J.M., and Fridovich I. The reduction of cytochrome C by milk xanthine oxidase. J. Biol. Chem. 243 (1968) 5753-5760
28. Mesenge C., Margaill I., Verrechia C., Allix M., Boulu R.G., and Plotkine M. Protective effect of melatonin in a model of traumatic brain injury in mice. J. Pineal Res. 25 (1998) 41-46
29. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86 (1978) 271-278
30. Noda Y., Mori A., Liburty R., and Packer L. Melatonin and its precursors scavenge nitric oxide. J. Pineal Res. 27 (1999) 159-164
31. Ozbek E., Turkoz Y., Gokdeniz R., Davarci M., and Ozugurlu F. Increased nitric oxide production in the spermatic vein of patients with varicocele. Eur. Urol. 37 (2000) 172-175
32. Pang S.F., Tsang C.W., Hong G.X., Yip P.C., Tang P.L., and Brown G.M. Fluctuation of blood melatonin concentrations with age: result of changes in pineal melatonin secretion, body growth, and aging. J. Pineal Res. 8 (1990) 179-192
33. Peunova N., and Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 364 (1993) 450-453
34. Poeggeler B., Reiter R.J., Tan D.X., Chen L.D., and Manchester L.C. Melatonin hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J. Pineal Res. 14 (1993) 151-168
35. Prajda N., and Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett. 59 (1975) 245-249
36. Reiter R.J. Interactions of pineal hormone melatonin with oxygen-centered free radicals: a brief review. Braz. J. Med. Biol. Res. 26 (1993) 1141-1155
37. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9 (1995) 526-533
38. Reiter R.J. Cytoprotective properties of melatonin: presumed association with oxidative damage and aging. Nutrition 14 (1998) 691-696
39. Reiter R.J., Guerrero J.M., Garcia J.J., and Acuna-Castroviejo D. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann. N.Y. Acad. Sci. 20 (1998) 410-424
40. Reiter R.J., Acune-Castroviejo D., Tan D.X., and Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann. N.Y. Acad. Sci. 939 (2001) 200-215
41. Ressmeyer A.R., Mayo J.C., Zelsko V., Sainz R.M., Tan D.X., Poeggeler B., Antoli I., Zsizsik B.K., Reiter R.J., and Hardeland R. Antioxidant properties of melatonin metabolite N1-acetyl-ethoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep. 8 (2003) 205-213
42. Sarrafzadeh A.S., Thomale U.W., Kroppenstedt S.N., and Unterberg A.W. Neuroprotective effect of melatonin on cortical impact injury in the rat. Acta Neurochir. 142 (2000) 1293-1299
43. Skene D.J., Vivien-Roels B., Sparks D.L., Hunsaker J.C., Pevet P., Ravid D., and Swaab D.F. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res. 24 (1990) 170-174
44. Sofic E., Rimpapa Z., Kundurovic S., Sapcanin A., Tahirovic I., Rustembegovic A., and Cao G. Antioxidant capacity of the neurohormone melatonin. J. Neural Transm. 112 (2005) 349-358
45. Solaroglu I., Okutan O., Kaptanoglu E., Beskonakli E., and Kilinc K. Increased xanthine oxidase activity after traumatic brain injury in rats. J. Clin. Neurosci. 12 (2005) 273-275
46. Tan D.X., Manchester L.C., Burkhardt S., Sainz R.M., Mayo J.C., Kohen R., Shohami E., Huo Y.S., Hardeland R., and Reiter R.J. N1-acetyl-N2-formyl-5-ethoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15 (2001) 2294-2296
47. Vural H., Sabuncu T., Arslan S.O., and Aksoy N. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J. Pineal Res. 31 (2001) 193-198
48. Yakovlev A.G., and Faden A.I. Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx 1 (2004) 5-16
49. Yeleswaram K., McLaughlin L.G., Knipe J.O., and Schabdach D. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J. Pineal Res. 22 (1997) 45-51
50. Zang L.Y., Comsa G., Gardner H., and Vallyathan V. Scavenging of reactive oxygen species by melatonin. Biochim. Biophys. Acta 27 (1998) 469-477
51. Zhou J.N., Liu R.L., Kamphorst W., Hofman M.A., and Swaab D.F. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J. Pineal Res. 35 (2003) 125-130